Researchers quantified the real-world risk for hospitalization among adults diagnosed with respiratory syncytial virus (RSV) in outpatient settings in a study presented in JAMA Network Open. They examined all-cause 28-day hospitalization following outpatient RSV infections among all adults as well as a high-risk subgroup of adults across 6 RSV seasons comprising 67,239 outpatient infections. Data revealed approximately 5% of adults experienced all-cause hospitalization within 28 days following outpatient RSV infections. The analysis showed an absolute risk of all-cause hospitalization ranging from 4.5% to 6.2% among those diagnosed in the outpatient setting.
There’s a vaccine for that: The Centers for Disease Control and Prevention recommends that all adults aged 75 and older receive the RSV vaccine as well as those aged 60-74 with risk factors. Read more on RSV hospitalizations from the JUCM archives: COVID-19 and RSV: Coinfection Requiring Hospitalization